Markets:

Overview

News

Currencies

International

Treasuries

Veracyte, Inc. - Common Stock (NQ:VCYT)

35.77 +0.62 (+1.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Veracyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Earnings Scheduled For February 24, 2025 ↗

February 24, 2025

Via Benzinga

Why VERACYTE INC (NASDAQ:VCYT) qualifies as a high growth stock. ↗

February 06, 2025

A fundamental and technical analysis of (NASDAQ:VCYT): Is VERACYTE INC (NASDAQ:VCYT) suited for high growth investing?

Via Chartmill

Demystifying Veracyte: Insights From 7 Analyst Reviews ↗

January 29, 2025

Via Benzinga

Exploring NASDAQ:VCYT's high growth characteristics. ↗

January 14, 2025

Why VERACYTE INC (NASDAQ:VCYT) qualifies as a high growth stock.

Via Chartmill

Should you consider VERACYTE INC (NASDAQ:VCYT) for high growth investing? ↗

December 18, 2024

Unlocking the high Growth Potential of VERACYTE INC (NASDAQ:VCYT).

Via Chartmill

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 ↗

January 14, 2025

Cathie Wood-led Ark Invest sold 140,518 shares of Palantir and bought shares of Tempus AI Inc. The total value of the trades is about $9.1 million.

Via Benzinga

Topics Artificial Intelligence

Navigating 9 Analyst Ratings For Veracyte ↗

December 05, 2024

Via Benzinga

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared? ↗

November 26, 2024

Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Via Benzinga

Topics Artificial Intelligence

Is NASDAQ:VCYT a Fit for high Growth Investing Strategies? ↗

November 22, 2024

Should you consider VERACYTE INC (NASDAQ:VCYT) for high growth investing?

Via Chartmill

Smaller Cap Biotechs Are In Season: How Are We Doing? ↗

November 07, 2024

SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.

Via Talk Markets

Breaking Down Veracyte: 4 Analysts Share Their Views ↗

October 10, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Veracyte Through 4 Analysts ↗

May 08, 2024

Via Benzinga

Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

September 16, 2024

A Relative Strength Rating upgrade for Tempus AI shows improving technical performance.

Via Investor's Business Daily

Topics Artificial Intelligence

Thermo Fisher Scientific Stock Sees RS Rating Jump To 81 ↗

August 13, 2024

Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81.

Via Investor's Business Daily

Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? ↗

August 11, 2024

Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in them?

Via Benzinga

Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View ↗

August 07, 2024

Veracyte reports Q2 sales of $114.43M, a 27% increase year over year, surpassing the $100.3 million consensus. Testing revenue rose 31% to $107 million, driven by strong performance of Decipher...

Via Benzinga

Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday ↗

August 07, 2024

Via Benzinga

Recap: Veracyte Q4 Earnings ↗

February 22, 2024

Via Benzinga

Earnings Outlook For Veracyte ↗

February 21, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 07, 2024

Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!

Via InvestorPlace

VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

The 3 Best Personalized Nutrition Stocks to Buy Now ↗

July 24, 2024

Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions.

Via InvestorPlace

Topics Artificial Intelligence

Trading SMID Biotech Stocks In A Volatile Market ↗

July 01, 2024

Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...

Via Talk Markets

Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness ↗

June 10, 2024

On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a...

Via Benzinga

VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally ↗

February 28, 2024

On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares.

Via Benzinga

Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold ↗

February 27, 2024

On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.

Via Benzinga

Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed ↗

February 26, 2024

On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ:

Via Benzinga

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff ↗

February 26, 2024

Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.

Via InvestorPlace

Earnings Scheduled For February 22, 2024 ↗

February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Veracyte, Inc. - Common Stock (NQ:VCYT)

Headline News about Veracyte, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today